Publications by authors named "Chong-Shan Lv"

Olfactory dysfunction is increasingly recognized as an early indicator of Alzheimer's disease (AD). Aberrations in GABAergic function and the excitatory/inhibitory (E/I) balance within the olfactory bulb (OB) have been implicated in olfactory impairment during the initial stages of AD. While the neuregulin 1 (NRG1)/ErbB4 signaling pathway is known to regulate GABAergic transmission in the brain and is associated with various neuropsychiatric disorders, its specific role in early AD-related olfactory impairment remains incompletely understood.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) is difficult to diagnose early, but retinal damage may indicate its onset before cognitive decline occurs.
  • Salvianolic acid B (Sal B), derived from a traditional Chinese herb, shows potential in treating early-stage AD and retinopathy.
  • In a study with 5×FAD mice, Sal B treatment improved retinal function and structure, suggesting it could help address early symptoms of AD by reducing harmful protein buildup and inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • Olfactory dysfunction is one of the first signs of Parkinson's disease, linked to α-synuclein accumulation in the olfactory bulb.
  • Research on SNCA-A53T mice revealed that while their motor skills remained unaffected, their ability to detect and differentiate odors was impaired due to abnormal signaling in the olfactory bulb.
  • The study found that targeting GABA signaling with tiagabine improved olfactory function, suggesting a new approach for diagnosing and treating early-stage Parkinson's disease.
View Article and Find Full Text PDF

Objective: The aim of this study was to explore potential immunoregulatory mechanisms underlying the suppressive effect on atherosclerosis of QiShenYiQi pill (QSYQ).

Methods And Results: Male ApoE mice were maintained on a Western-type diet and QSYQ treatment for eight weeks. Determination of atherosclerosis demonstrated that QSYQ attenuated plaque formation and decreased the level of blood low-density lipoproteins-cholesterol.

View Article and Find Full Text PDF